Skip to content
FlowDesk
Sign inCreate free accountStart free
● Sat 10 Oct 2026/US closed · opens Mon 14:30 BST/109 names scored today/last score 11:07 BSTResearch, not advice · every call is published at Proof
Stocks / ABBV vs MRNA, ENGN · /stock/ABBV?vs=MRNA,ENGN (was /compare/ABBV,MRNA,ENGN)

ENGN has the strongest read; MRNA has the most behind it.

No lean bullish, one bearish. The difference is evidence and record: MRNA’s read rests on 52,509 contracts but our 4h record on it is 23%; ENGN’s bucket hasn’t paid historically.

+
Side by sideOverlay history Copy link
Sign in to save these 3 names as a list.
ABBV AbbVie · Biotechnology×
MRNA Moderna · Biotechnology×
ENGN enGene Therapeutics · Biotechnology×
The readNeutralNeutralStrongly bearish
−100 · 0 · +100
Composite−4.2−5.9−83.3
Evidence 62 75 68
Quality879260
Price$274.62$194.91$1.75
Contracts today3,21852,5093,311
Calibrationneutral · +9.94% · n=4,567neutral · +1.15% · n=1,055hasn’t paid +0.10% · n=21,921
30d tape (ink) vs price (dashed)
Our record here, 4h9% of 815 checked23% of 761 checked4% of 1,389 checked
02

Tape, 43 days, same axis

ABBVMRNAENGNtape_history · hourly, daily close shown

All values from the same rows as each stock page (stock_scores, tape_history, score_outcomes, tape calibration). Compare keeps the stock-page glyphs so nothing needs relearning.

Ask
Add PURRWhy is MRNA’s record 23%?